News & Views
Scientists discover potential new cancer treatment
Mar 29 2011
Published in BioMed Central's BMC Cancer Journal, the research tracks the use of "artificial plasmid coding for the replicase genes of the Sindbis virus".
Sindbis is an alpha virus that contains on a single strand of RNA its genetic information, something that is replicated into a double strand upon infection.
This is then attacked by the body. Researchers have used this principle to target tumours in mice in a clinical laboratory - and have seen some effect.
Based at the University of Texas in Austin, the researchers saw tumours begin to regress after 25 days.
After 37 days, all tumours were either gone or had begun to shrink.
"In our study both highly immunogenic and poorly immunogenic tumours were receptive to treatment with an RNA replicase based plasmid. Our results suggested a novel approach to cancer molecular therapy," comments Professor Cui.
BMC Cancer is an open access journal, reviewed by peers, publishing research related to all aspects of the illness.
Digital Edition
International Labmate Buyers' Guide 2024/25
June 2024
Buyers' Guide featuring: Product Listings & Manufacturers Directory Chromatography Articles - Enhancing HPLC Field Service with fast-response, non-invasive flowmeters - Digital transformatio...
View all digital editions
Events
Jul 07 2024 Dublin, Ireland
Jul 20 2024 Denver, CO, USA
Jul 21 2024 Cape Town, South Africa
Jul 28 2024 San Diego, CA USA
Jul 30 2024 Jakarta, Indonesia